Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Cash & Equivalents | 89.05 | 82.91 | 5.72 | 6.75 | 11.63 | 19.76 | |
| Cash & Short-Term Investments | 89.05 | 82.91 | 5.72 | 6.75 | 11.63 | 19.76 | |
| Cash Growth | 53.80% | 1349.43% | -15.23% | -41.97% | -41.15% | 2370.22% | |
| Other Receivables | 0.5 | 0.41 | 0.05 | 0.04 | 0.16 | 0.11 | |
| Receivables | 0.5 | 0.41 | 0.05 | 0.04 | 0.16 | 0.11 | |
| Prepaid Expenses | 1.24 | 0.99 | 0.22 | 0.03 | 0.16 | 0.17 | |
| Total Current Assets | 90.79 | 84.31 | 5.99 | 6.81 | 11.95 | 20.04 | |
| Property, Plant & Equipment | 0.09 | 0.11 | 0.12 | 0.07 | 0.14 | - | |
| Other Intangible Assets | - | - | - | - | - | 0 | |
| Accounts Payable | 1.43 | 1.71 | 0.41 | 0.18 | 1.25 | 0.6 | |
| Accrued Expenses | 0.06 | 0.54 | 0.04 | 0.03 | 0.16 | 0.04 | |
| Current Portion of Leases | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | - | |
| Total Current Liabilities | 1.58 | 2.34 | 0.53 | 0.28 | 1.47 | 0.64 | |
| Long-Term Leases | 0.02 | 0.04 | 0.04 | - | 0.07 | - | |
| Common Stock | 136.77 | 123.25 | 35.42 | 33.91 | 32.24 | 27.08 | |
| Retained Earnings | -54.14 | -46.58 | -34.35 | -31.55 | -24.17 | -9.21 | |
| Comprehensive Income & Other | 6.65 | 5.37 | 4.46 | 4.23 | 2.48 | 1.53 | |
| Total Liabilities & Equity | 90.88 | 84.42 | 6.1 | 6.88 | 12.09 | 20.04 | |
| Total Debt | 0.1 | 0.13 | 0.12 | 0.07 | 0.14 | - | |
| Net Cash (Debt) | 88.94 | 82.78 | 5.6 | 6.67 | 11.49 | 19.76 | |
| Net Cash Growth | 54.11% | 1377.97% | -16.08% | -41.90% | -41.86% | 2370.22% | |
| Net Cash Per Share | 12.22 | 12.04 | 1.30 | 1.79 | 4.65 | 11.01 | |
| Filing Date Shares Outstanding | 9.79 | 7.79 | 6.99 | 4.46 | 3.74 | 2.37 | |
| Total Common Shares Outstanding | 7.79 | 7.64 | 4.52 | 3.77 | 3.52 | 2.37 | |
| Working Capital | 89.21 | 81.97 | 5.46 | 6.53 | 10.48 | 19.4 | |
| Book Value Per Share | 11.47 | 10.74 | 1.22 | 1.75 | 3.00 | 8.20 | |
| Tangible Book Value | 89.28 | 82.04 | 5.54 | 6.6 | 10.54 | 19.4 | |
| Tangible Book Value Per Share | 11.47 | 10.74 | 1.22 | 1.75 | 3.00 | 8.20 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.